[Topical treatment of bleeding post removed teeth in patients with prosthetic heart valves whose receiving long-term of oral anticoagulant therapy].
Removed teeth in patients receiving long-term oral anticoagulant drugs there are all the time live insure, very important and controversial problem in stomatological practice. Continuation of anticoagulation oral drugs exposure the patients so long haemorrhage while withdraw anticoagulant therapy to induce the risk of thromboembolism. The investigation were in 53 patients with prosthetic heart valves whose treated oral anticoagulant agents. The all patients have removed teeth without withdraw anticoagulant therapy. TachoComb administrated in alveoli post extraction teeth. The hemorrhage were in 4 (7.54%) cause.
Lewandowski
Bogumił
B
Oddział Chirurgii Szczekowo-Twarzowej Wojewódzkiego Szpitala Specjalistycznego, Rzeszowie.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects; D007611:Aprotinin / Q000627:therapeutic use*; D016022:Case-Control Studies; D004338:Drug Combinations; D005260:Female; D005340:Fibrinogen / Q000627:therapeutic use*; D006350:Heart Valve Prosthesis; D006488:Hemostasis, Surgical / Q000379:methods*; D006490:Hemostatics / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D006472:Oral Hemorrhage / Q000517:prevention & control*; D013917:Thrombin / Q000627:therapeutic use*; D013923:Thromboembolism / Q000517:prevention & control; D013997:Time Factors; D014081:Tooth Extraction; D016896:Treatment Outcome
D000925:Anticoagulants; D004338:Drug Combinations; D006490:Hemostatics; C093991:tachocomb; D005340:Fibrinogen; D007611:Aprotinin; D013917:Thrombin